Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Asker Healthcare Group AB ( (SE:ASKER) ) has shared an update.
Asker Healthcare Group has reshuffled its senior leadership, appointing current M&A Director Lovisa Hedin as Head of M&A and promoting Head of HR Kerstin Mjömark to Head of HR and ESG, effective 1 April, while current M&A chief Ola Nordh and ESG head Sanna Norman will depart later in the year after a transition period. CEO Johan Falk highlighted Hedin’s central role in building Asker’s decentralized, locally driven M&A model and its strong acquisition pipeline, and underscored the strategic importance of integrating ESG work into local businesses under Mjömark’s leadership to meet the group’s 2030 sustainability targets, reinforcing the company’s growth and sustainability agenda within the European healthcare market.
The most recent analyst rating on (SE:ASKER) stock is a Hold with a SEK78.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare group that partners with caregivers and patients across Europe, supplying medical products and solutions through a portfolio of locally run companies. The group focuses on improving patient outcomes, reducing the total cost of care and promoting a fair and sustainable value chain, leveraging both entrepreneurial local operations and the scale and expertise of a larger group. Asker has more than 4,500 employees in 19 countries and generates revenues of about SEK 16 billion.
Average Trading Volume: 532,934
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK28.36B
See more insights into ASKER stock on TipRanks’ Stock Analysis page.